MORGAN STANLEY - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 79 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2016. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$23,128,000
+395.9%
967,722
+202.8%
0.00%
+200.0%
Q4 2020$4,664,000
-52.8%
319,555
-54.1%
0.00%
-50.0%
Q3 2020$9,877,000
+1521.8%
695,624
+1579.0%
0.00%
Q2 2020$609,000
-96.8%
41,431
-99.1%
0.00%
-100.0%
Q1 2020$18,918,000
-23.7%
4,591,855
-10.9%
0.01%
-16.7%
Q4 2019$24,790,000
-0.3%
5,153,830
+25.6%
0.01%
-14.3%
Q3 2019$24,873,000
+110.1%
4,104,550
+125.0%
0.01%
+133.3%
Q2 2019$11,841,000
+388.9%
1,824,449
+434.0%
0.00%
+200.0%
Q1 2019$2,422,000
+141.2%
341,662
+65.4%
0.00%
Q4 2018$1,004,000
-80.4%
206,544
-70.4%
0.00%
-100.0%
Q3 2018$5,132,000
-6.7%
698,321
-19.0%
0.00%0.0%
Q2 2018$5,503,000
+48.4%
862,513
+26.5%
0.00%0.0%
Q1 2018$3,709,000
+23.7%
681,747
-5.2%
0.00%0.0%
Q4 2017$2,999,000
-64.9%
719,168
-19.0%
0.00%
-66.7%
Q3 2017$8,547,000
-25.6%
887,560
-8.6%
0.00%0.0%
Q2 2017$11,485,000
-65.2%
970,825
-62.2%
0.00%
-40.0%
Q1 2017$32,956,000
-41.8%
2,570,510
-44.5%
0.01%
-44.4%
Q4 2016$56,644,000
+69.6%
4,627,844
+63.5%
0.01%
-18.2%
Q3 2016$33,390,000
+97.3%
2,829,658
+45.5%
0.01%
+83.3%
Q2 2016$16,922,000
+123.0%
1,945,083
+35.1%
0.01%
+100.0%
Q1 2016$7,588,000
-26.9%
1,439,981
+7.6%
0.00%
-25.0%
Q4 2015$10,385,000
+10285.0%
1,338,286
+10433.5%
0.00%
Q3 2015$100,000
-76.5%
12,705
-73.0%
0.00%
Q2 2015$426,000
-66.7%
46,986
-52.3%
0.00%
Q1 2015$1,279,000
+7.8%
98,584
+13.1%
0.00%
Q4 2014$1,186,000
+204.1%
87,156
+99.9%
0.00%
Q3 2014$390,000
-41.4%
43,606
-11.2%
0.00%
Q2 2014$665,000
+56.8%
49,094
+15.3%
0.00%
Q1 2014$424,000
-24.0%
42,586
+1.4%
0.00%
Q4 2013$558,000
+20.5%
42,017
+10.2%
0.00%
Q3 2013$463,000
-37.2%
38,114
-46.5%
0.00%
Q2 2013$737,00071,2760.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders